Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Axsome Therapeutics, Inc. (AXSM)
Sector: Healthcare; Industry: Biotechnology

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the phase III clinical trial for the treatment resistant depression and depressive disorders; and phase II/III clinical trials in agitation associated with Alzheimer's disease, as well as completed phase II clinical trial for the treatment of smoking cessation. The company was founded in 2012 and is based in New York, New York.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-12 Coleman Mark Director Buy 500 $58.15 $29,075 No
2020-06-29 Coleman Mark Director Buy 650 $78.50 $51,025 No
2020-06-29 Pizzie Nick Chief Financial Officer Buy 777 $76.64 $59,549 No
2019-09-26 Pizzie Nick Chief Financial Officer Buy 2,180 $24.80 $54,064 No
2019-06-26 Coleman Mark Director Buy 16,200 $23.10 $374,280 No
2019-06-11 Pizzie Nick Chief Financial Officer Buy 1,920 $20.80 $39,936 No
2019-05-23 Saad Mark E Director Buy 3,500 $22.33 $78,155 No
2019-05-13 Coleman Mark Director Buy 4,650 $21.44 $99,696 No
2019-03-19 Pizzie Nick Chief Financial Officer Buy 5,400 $12.58 $67,939 No
2019-03-19 Coleman Mark Director Buy 5,100 $12.18 $62,118 No
2018-06-19 Pizzie Nick Chief Financial Officer Buy 31,000 $3.10 $96,080 No
2015-12-23 Kaye Randall Chief Medical Officer Buy 1,000 $9.03 $9,026 No

Insider Smart

Camping World Holdings, Inc (CWH) - Another crash victim, Camping World Holdings, Inc took a deep dive from $16 to $4, several insiders bought around $6. With insiders on your side, this would be an easy add and hold to get your cost under $6. A 300% gain because stock is about to breach $25 in the coming weeks.

Insider Smart

Enphase Energy, Inc (ENPH) - ENPH was $10+ in 15Q1 then dropped to $2 and eventually went under $1. From 15Q4 to 17Q4 it built a 2-year-long base then BOOM! Stock went as high as $70 and likely will make a new high. Catch one or two moves like this you can retire early. One hint before the big move was that CEO and CFO were constantly accumulating, this kind of information is priceless.